Drug intelligence / Profile preview

NANOS1 + colloidal silver

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems
Administration
Oral, Topical, Intranasal
01

Overview

NANOS1 + colloidal silver is a combination product consisting of two components: - **NANOS1**: There is no evidence in the provided sources or in widely available scientific literature that "NANOS1" refers to an approved drug, supplement, or recognized active pharmaceutical ingredient. It may be a code name, research compound, or proprietary formulation not documented in major databases. - **Colloidal Silver**: Colloidal silver consists of tiny particles of elemental silver suspended in liquid. Historically used for its purported antimicrobial properties before the advent of antibiotics, it has been marketed as a dietary supplement and topical agent for wound healing. However, there is no clinical evidence supporting its effectiveness for any disease or condition when taken orally or applied topically[1][2][3]. The FDA does not recognize it as safe or effective for any medical use[6]. The mechanism of action attributed to colloidal silver involves disruption of microbial cell membranes and proteins via released Ag+ ions and induction of oxidative stress within pathogens[5][8]. Despite these laboratory findings, clinical efficacy remains unproven.

Other names
NANOS1 and colloidal silverNANOS-1 and colloidal silverNANOS 1 and colloidal silverNANOS1 plus colloidal silverNANOS-1 plus colloidal silverNANOS 1 plus colloidal silver

Beyond the preview

Go deeper on NANOS1 + colloidal silver.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NANOS1 + colloidal silver.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call